Drug Shortage Report for MYLAN-MIRTAZAPINE
Report ID | 146990 |
Drug Identification Number | 02256118 |
Brand name | MYLAN-MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 30MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-12-08 |
Actual start date | |
Estimated end date | 2021-12-14 |
Actual end date | 2021-10-18 |
Shortage status | Avoided shortage |
Updated date | 2021-10-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-10-13 | English | Compare |
v2 | 2021-10-13 | French | Compare |
v3 | 2021-10-26 | English | Compare |
v4 | 2021-10-26 | French | Compare |
Showing 1 to 4 of 4